MENU
LENZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LENZ Therapeutics (LENZ) Ownership - Who owns LENZ Therapeutics?
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products... Show more
Profile
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
504.59M
P/E Ratio
N/A
Total Cash
209.03M
Projected Growth
N/A
Total Debt
1.38M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.59
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LENZ
Capitalization
505M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
209M
Total Cash/Share
7.59
Total Debt
1.38M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
204M
P/B Ratio
2.47
Cash Flow
N/A
Earnings
-2.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
20.36
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-58.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.84
Shares Held By Institutions
1.81B
Shares Outstanding - Current
27.5M
Total Liabilities
11.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-36.543
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
445 Marine View Avenue
Phone
+1 858 925-7000
Employees
N/A
Web
https://www.lenz-tx.com